(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DE HIV COM CABOTEGRAVIR E RILPIVIRINA EM PACIENTES PEDIÁTRICOS

Em AnáliseInvention PatentPCT · EP2023075264

Application data

Number

112025004876

Type

Invention Patent

Filing

09/14/2023

Publication

09/30/2025

PCT

EP2023075264

Progress at the INPI

Examination not yet requested
  1. Filing09/14/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 09/14/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:09/14/2026(20 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/30/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

IE

VIIV HEALTHCARE UK (NO.3) LIMITED

GB

See this company's full portfolio

Inventors

A. R. (pessoa física)

IT

H. C. (pessoa física)

BE

S. C. (pessoa física)

GB

Y. L. (pessoa física)

AU

Technical data

Priority claims

US

63/407,425 · 09/16/2022

Abstract

TRATAMENTO DE HIV COM CABOTEGRAVIR E RILPIVIRINA EM PACIENTES PEDIÁTRICOS. A revelação fornece um método de tratamento de infecção por HIV em um paciente pediátrico humano pela administração de cabotegravir ou um sal farmaceuticamente aceitável do mesmo, em combinação com rilpivirina ou um sal farmaceuticamente aceitável da mesma.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

09/30/2025

RPI 2856

Alteração de dados cadastrais

#1.1

03/25/2025

RPI 2829

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.